BioStock: Lipum is at the final step before clinical phase

Late last week, Lipum announced that the toxicology and safety studies with the drug candidate SOL-116 are proceeding according to plan. The company has started the final study before a Clinical Trial Application can be filed and it looks like the first clinical trial with SOL-116 is on track to begin next year. BioStock contacted Anneli Hällgren, project manager for the toxicology and safety program, to learn more about the progress in the preclinical work. 

Read the full interview at biostock.se: 

https://www.biostock.se/en/2021/09/lipum-is-at-the-final-step-before-clinical-phase/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se